The focus of this review is current knowledge about the epidemiology, clinical
manifestations, diagnosis, and treatment of both pulmonary sarcoidosis and extrapulmonary …

Sarcoidosis is a common systemic, noncaseating granulomatous disease of unknown
etiology. The development of sarcoidosis has been associated with a number of …

Objective To characterize the epidemiology of sarcoidosis from 1946 through 2013. Patients
and Methods An inception cohort of patients with incident sarcoidosis from January 1, 1976 …

Sarcoidosis is a multisystem granulomatous disorder that most often affects the lungs and
may cause significant morbidity. Sarcoidosis can manifest as neurological disease, uveitis …

Sarcoidosis is a chronic inflammatory disease of unknown etiology characterized by multi-
organ involvement. End-organ disease consists of granulomatous inflammation, which if left …

Sarcoidosis is a systemic granulomatous disease associated with local epithelioid
granulomas, CD4+ T cells, and Th1 cytokines. The tissue Ags that drive this granulomatous …

Sarcoidosis, a systemic granulomatous disease of undetermined etiology, is characterized
by a variable clinical presentation and course. During the past decade, advances have been …

The immune system is equipped with a plethora of mechanisms that protect the host from the
harmful effects of environmental insults. However, the traditional “hierarchical” view of the …

Rationale: Sarcoidosis is a granulomatous disease of unknown etiology, although M.
tuberculosis may play a role in the pathogenesis. The traditional view holds that …

Sarcoidosis is a granulomatous inflammatory disorder of unclear etiology, which is known to
affect multiple organ systems including the lungs, heart, skin, central nervous system, and …